Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA replication and sister chromatid cohesion 1 (DSCC1) is a protein that is a critical component of the alternative replication factor C (RFC) complex known as the CTF18-RFC complex, which includes CTF18, DSCC1, and CTF8. This complex is responsible for loading the proliferating cell nuclear antigen (PCNA) onto DNA during the S phase of the cell cycle. DSCC1's main functions are to support proper DNA replication, regulate replication fork progression, and ensure the establishment of sister chromatid cohesion necessary for accurate chromosome segregation. DSCC1 is overexpressed in several cancer types, where it promotes cell proliferation, tumor growth, and resistance to apoptosis, making it a potential prognostic biomarker and therapeutic target. Gene amplification and high expression levels of DSCC1 correlate with adverse prognosis in liver, breast, and colorectal cancers. No approved drugs are known to specifically target DSCC1 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA replication and sister chromatid cohesion 1 (DSCC1).